What is Annapath?
Annapath Pathology Services operates as a privately owned laboratory, extending its specialized diagnostic capabilities across Maryland, Delaware, Pennsylvania, Washington D.C., Virginia, and West Virginia. The company's core services encompass a comprehensive suite of pathology testing, including Gastrointestinal, Genitourinary, and Gynecological analyses. Annapath is committed to delivering timely and precise results, fostering a strong foundation of trust with physicians and patients through personalized support and direct access to Board Certified pathologists. With established facilities in Bowie, Maryland, and Annandale, Virginia, Annapath prioritizes reliability and clear communication in its service delivery.
How much funding has Annapath raised?
Annapath has raised a total of $629K across 2 funding rounds:
Debt
$150K
Debt
$479K
Debt (2020): $150K with participation from PPP
Debt (2021): $479K led by PPP
Key Investors in Annapath
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Annapath?
The recent major strategic investment signifies Annapath's transition into a scaling phase, likely enabling expansion of its service offerings, technological advancements in diagnostic capabilities, and broader market penetration within its operational regions. This capital infusion is expected to bolster its competitive edge in the pathology services market, potentially leading to enhanced operational efficiencies and further solidifying its reputation for accuracy and physician support. The company's focus on core pathology services suggests a strategic intent to deepen its expertise and market share in these critical diagnostic areas.
See full Annapath company page
